A detailed history of National Asset Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, National Asset Management, Inc. holds 10,389 shares of VRTX stock, worth $4.83 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,389
Previous 9,443 10.02%
Holding current value
$4.83 Million
Previous $3.95 Million 23.36%
% of portfolio
0.13%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

BUY
$392.81 - $485.53 $371,598 - $459,311
946 Added 10.02%
10,389 $4.87 Million
Q1 2024

May 16, 2024

BUY
$407.69 - $446.08 $41,584 - $45,500
102 Added 1.09%
9,443 $3.95 Million
Q4 2023

Mar 15, 2024

SELL
$343.0 - $410.68 $34,986 - $41,889
-102 Reduced 1.08%
9,341 $3.8 Million
Q3 2023

Dec 01, 2023

SELL
$338.18 - $362.46 $264,456 - $283,443
-782 Reduced 7.65%
9,443 $3.28 Million
Q2 2023

Jul 27, 2023

SELL
$314.42 - $351.91 $628 - $703
-2 Reduced 0.02%
10,225 $3.6 Million
Q1 2023

May 17, 2023

SELL
$283.23 - $323.1 $1.6 Million - $1.82 Million
-5,638 Reduced 35.54%
10,227 $3.22 Million
Q4 2022

Feb 21, 2023

SELL
$285.76 - $321.48 $252,040 - $283,545
-882 Reduced 5.27%
15,865 $4.58 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $289,438 - $322,945
1,057 Added 6.74%
16,747 $4.85 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $127,348 - $158,562
-542 Reduced 3.34%
15,690 $4.42 Million
Q1 2022

May 02, 2022

BUY
$221.42 - $260.97 $978,233 - $1.15 Million
4,418 Added 37.4%
16,232 $4.24 Million
Q4 2021

Jan 28, 2022

SELL
$177.01 - $223.45 $886,289 - $1.12 Million
-5,007 Reduced 29.77%
11,814 $2.6 Million
Q3 2021

Nov 16, 2021

BUY
$181.39 - $202.99 $200,254 - $224,100
1,104 Added 7.02%
16,821 $3.1 Million
Q2 2021

Aug 10, 2021

BUY
$187.49 - $221.1 $122,805 - $144,820
655 Added 4.35%
15,717 $3.2 Million
Q1 2021

May 13, 2021

BUY
$207.02 - $241.31 $602,842 - $702,694
2,912 Added 23.97%
15,062 $3.27 Million
Q4 2020

Feb 04, 2021

SELL
$207.01 - $276.09 $103,505 - $138,045
-500 Reduced 3.95%
12,150 $2.87 Million
Q3 2020

Nov 09, 2020

BUY
$255.65 - $303.1 $813,222 - $964,161
3,181 Added 33.59%
12,650 $3.5 Million
Q2 2020

Jul 31, 2020

BUY
$225.48 - $295.8 $332,132 - $435,713
1,473 Added 18.42%
9,469 $2.75 Million
Q1 2020

May 06, 2020

BUY
$199.77 - $247.81 $509,613 - $632,163
2,551 Added 46.85%
7,996 $1.9 Million
Q4 2019

Feb 10, 2020

BUY
$166.71 - $223.91 $335,420 - $450,506
2,012 Added 58.61%
5,445 $1.19 Million
Q3 2019

Nov 12, 2019

BUY
$166.23 - $187.09 $136,973 - $154,162
824 Added 31.58%
3,433 $583,000
Q2 2019

Aug 05, 2019

SELL
$164.61 - $190.37 $145,844 - $168,667
-886 Reduced 25.35%
2,609 $480,000
Q1 2019

May 08, 2019

BUY
$163.73 - $194.7 $30,453 - $36,214
186 Added 5.62%
3,495 $644,000
Q4 2018

Feb 08, 2019

BUY
$151.91 - $192.21 $19,748 - $24,987
130 Added 4.09%
3,309 $549,000
Q3 2018

Nov 08, 2018

SELL
$167.73 - $192.74 $13,250 - $15,226
-79 Reduced 2.42%
3,179 $615,000
Q2 2018

Oct 05, 2018

BUY
$145.72 - $169.96 $87,140 - $101,636
598 Added 22.48%
3,258 $555,000
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $90,050 - $105,215
594 Added 28.75%
2,660 $434,000
Q4 2017

Feb 15, 2018

SELL
$137.28 - $155.55 $293,367 - $332,410
-2,137 Reduced 50.84%
2,066 $310,000
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $347,216 - $380,290
2,344 Added 126.09%
4,203 $597,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,859
1,859 $240,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.